Multiplexed Nucleic Acid Self-Test for Reproducible and Sensitive HIV Detection

Awarded Award Notice Posted

Solicitation number
PHS-2025-1
Agency
National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Awarded
to Vivid Bioinnovations, PBC
Set-aside
Total Small Business

Opportunity facts

Contract number
75N93025C00029 Federal contract award
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN12 Health R&D Services; Health Care Services; Applied Research
Place of performance
San Francisco, California 94107, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, has awarded contract 75N93025C00029 to Fluid Discovery, Inc. for the development of a "Multiplexed Nucleic Acid Self-Test for Reproducible and Sensitive HIV Detection." The contract, valued at $2,566,049 including all options, supports research and development services to create advanced HIV detection self-test technology. The performance period spans four years, from September 1, 2025, through August 31, 2029, with the San Francisco-based company serving as the primary contractor for this specialized life sciences research project.

Notice text

Awarded contract 75N93025C00029 to FLUID DISCOVERY, INC. for 2566049.00 on 2025-08-28.

Attachments

Files attached to this notice, newest first
File Type Posted
Award Synopsis - Fluid Discovery.pdf PDF

Notice history

And 4 more award notices.

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity